Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report
- First Online:
- Cite this article as:
- Meeske, K., Smith, A.W., Alfano, C.M. et al. Qual Life Res (2007) 16: 947. doi:10.1007/s11136-007-9215-3
- 434 Downloads
Purpose The purpose of this study was to estimate prevalence of fatigue, identify correlates of fatigue and evaluate the relationship between fatigue and health-related quality of life (HRQOL) in a large cohort of disease-free breast cancer survivors.
Methods Participants are enrolled in the HEAL Study, a multi-center prospective study of women diagnosed with in-situ to Stage IIIA breast cancer. HEAL participants (n = 1183) completed a baseline and a 24-month follow-up interview. Women in this report (n = 800) also completed a quality of life questionnaire that included the Piper Fatigue Scale and the RAND SF-36 two to five years after diagnosis. Multivariate regression methods were used to identify significant factors associated with fatigue. SF-36 scores for fatigued survivors were compared to non-fatigued survivor scores and population norms.
Results Forty-one percent of the breast cancer survivors were fatigued. Significant correlates of fatigue included pain, cognitive problems, physical inactivity, weight gain/personal appearance and antidepressant use. Fatigue was associated with poorer HRQOL, most notably in areas of role and social functioning.
Conclusion This study provides further support for the conclusion that a significant proportion of breast cancer survivors experience fatigue that compromises HRQOL two to five years post-diagnosis.
KeywordsBreast cancer survivorsFatigueQuality of lifePiper Fatigue Scale
Health-Related Quality Of Life
Quality Of Life
Surveillance, Epidemiology and End Results
Health, Eating, Activity and Lifestyle
Revised-Piper Fatigue Scale
Breast Cancer Prevention Trial
Hormone-related Symptom Checklist